Sign in
8-K

Current Report

KALA BIO, Inc. Filed Acc 0001558370-22-010589

Acquisition or sale completed · Exit or restructuring costs · Delisting notice · Other events

  • Item 2.01 Completion of acquisition or disposition of assets
  • Item 2.05 Costs associated with exit or disposal activities
  • Item 3.01 Notice of delisting or failure to meet a listing standard
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading kala-20220708x8k.htm…